The Uromigos
The Uromigos
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 136: ESMO 2021: STAMPEDE Abiraterone for high-risk non-metastatic prostate cancer
18 minutes
Posted Sep 19, 2021 at 1:49 pm.
0:00
18:55
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Gert Attard describes this practice-changing plenary data.
Previous
Episode 135: ESMO 2021: The STAR Study
Next
Episode 137: ESMO 2021: PEACE1 overall survival in prostate cancer
← See all 501 episodes of The Uromigos